00741naa#a2200217#i#4500001001500000003001700015005001700032011001400049100004100063102000700104200012500111210008200236215001000318608002700328675005600355700001700411700001900428700001800447700001900465856003900484EN\\bibl\18093/en/manage/index20250809120232.6##a2409-3750##a20170912b2017####ek#y0engy0150####ca##aRU1#aUSING OF DAPAGLIFLOZIN BY PATIENT WITH DIABETES MELLITUS TYPE 2   AND NON-ALCOHOLIC FATTY LIVER DISEASEeJournal article1#aTulacLLC Information and publishing center Innovations and investmentsd2017##a6 с.##aJournal article2local##aМедицина. Охрана здоровья. 61#1aPrilepagS A#1aMedvedevagE V#1aDail'nevgV I#1aMakishevagR T4#atest.editorum.ruu/en/manage/index